# A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

> **NCT02079805** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 33 (actual)

## Conditions studied

- Essential Hypertension Complicated by Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Azilsartan
- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT02079805
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02079805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02079805, "A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02079805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*